Washington: A wearable skin patch may help children who are allergic to peanuts by delivering small doses of peanut protein, according to a new study that calls for the therapy to be further explored.
The study, published in the Journal of Allergy and Clinical Immunology, found that nearly half of those treated with the Viaskin Peanut patch for one year were able to consume at least 10 times more peanut protein than they were able to prior to treatment.
The biggest benefit came for those from 4 years old to 11 years old. Participants older than 12 didn't see as much of an effect, the study found.
The therapy works by training the immune system to tolerate small amounts of peanuts, said Dr Daniel Rotrosen, of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, which is funding the ongoing clinical trial.
"Other recent advances have relied on an oral route that appears difficult for approximately 10 to 15 percent of children and adults to tolerate," Rotrosen said.
While the trial found the immunotherapy treatment to be "potentially effective," it cautioned that the study is limited. Further investigation is needed to find out if "the modest clinical changes noted will be enhanced after a longer duration of therapy," the study said.
Those long-term results should be available in the future because the trial is continuing.
The Viaskin Peanut patch hasn't been approved by the Food and Drug Administration.
The study, published in the Journal of Allergy and Clinical Immunology, found that nearly half of those treated with the Viaskin Peanut patch for one year were able to consume at least 10 times more peanut protein than they were able to prior to treatment.
The biggest benefit came for those from 4 years old to 11 years old. Participants older than 12 didn't see as much of an effect, the study found.
"Other recent advances have relied on an oral route that appears difficult for approximately 10 to 15 percent of children and adults to tolerate," Rotrosen said.
Advertisement
Those long-term results should be available in the future because the trial is continuing.
Advertisement
COMMENTS
Advertisement
Australia Launches Life-Saving Peanut Allergy Treatment For Babies UK Woman Purchases 48 Packets Of Peanut While On Flight - Here's Why Overwatch 2’s Battle for Olympus Event Is Now Live, Heroes Fashioned After Greek Myth US Millionaire, Who Died By Suicide, Owed $34 Million With $8,000 In Bank What Is Symbiosexuality? New Form Of Sexual Attraction Explained By Experts Manipur Chief Minister Slams Tejashwi Yadav Over "Racist" Jab At Himanta Sarma IPS Officer Rajwinder Singh Bhatti Takes Charge As CISF Director General 13-Year-Old Pregnant After Rape By School Peon In UP's Farukkhabad: Cops 1962 Indo-China War Era Smoke Bomb Found In Assam, Safely Blasted: Police Track Latest News Live on NDTV.com and get news updates from India and around the world.